Login | New Member? Signup Free
ChangeDetect » News

Indian activists protesting against the Novartis patent case

Pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreements, say Peter Roderick and Allyson M Pollock.

Tags: , , , , , , , , , ,

J&j, Notre Dame, Prada, Louboutin, Apple: Intellectual Property

Johnson & Johnson and Novartis AG are under investigation by the European Union’s antitrust regulator over contracts that may have hampered the sale of generic versions of pain killer Fentanyl in the Netherlands.

Tags: , , , , , , , , , , , , , ,

Novartis increases growth potential through integration of Alcon

Novartis International AG / Novartis increases growth potential through integration of Alcon . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. * Alcon is innovative new growth

Tags: , , , , ,

Novartis, Alcon Join Alnylam in Opposing Silence Patent in Europe

Drug makers Novartis and Alcon have joined Alnylam Pharmaceuticals in opposing a European patent held by Silence Therapeutics covering a key RNAi molecule-design technology, according to documents on file with the European Patent Office. (1 day ago)

Tags: , , , , , , , ,

Lilly, Novartis, Rackspace, Time Warner, Microsoft: Intellectual Property

Eli Lilly & Co. , whose best-selling schizophrenia drug Zyprexa survived a U.K. court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain. (18 hours ago)

Tags: , , , , , , , , , , ,

Concern as Novartis exec approved to WHO group

An executive at Swiss group Novartis has been appointed to a World Health Organization body advising on research despite criticism it may lead to a conflict of interest. (11 mins ago)

Tags: , , , , ,